Polychlorinated biphenyls (PCBs) are persistent contaminants suspected to cause adverse health effects in humans. As PCBs levels in food have not been monitored frequently in the past, modeling approaches based on environmental data have been proposed to predict the human dietary intake. In this work, we propose to improve these approaches by taking into account internal levels of PCBs in humans. This methodology is based on the analysis of biomonitoring data using exposure and physiologically based pharmacokinetic (PBPK) modeling to determine the most probable scenario of exposure. Breast milk concentrations were measured in Italian women for PCB-138, PCB-153 and PCB-180. For each congener, three exposure scenarios were derived and a PBPK model was used to relate the lifetime exposure to the breast milk levels. For the three PCBs, we determined the most probable scenario of exposure. Our results support the adequacy of the exposure and the PBPK models for PCB-180 and PCB-153, whereas we observed discrepancies between the models and the biomonitoring data for PCB-138. Our intake estimates are in good agreement with previous exposure assessments based solely on food contamination demonstrating the relevance of our approach to reconstruct accurately the exposure and to fill in data gaps on exposure.
INTRODUCTION
From the 1920s until the ban in the 1970s, polychlorinated biphenyls (PCBs) were used in industries for their electrical insulating properties (e.g., in transformers, electrical capacitors and hydraulic fluids). Owing to their extensive use and persistence in the environment, PCBs are ubiquitous contaminants and significant amounts are still detectable in the environment. 1--3 Being extremely lipophilic, PCBs are bioaccumulated in humans and predators at the top of the food chain. 4 Ingestion of contaminated foods, particularly those of animal origin, is the main route of nonoccupational human exposure to PCBs. A wide range of adverse health effects is associated with exposure to PCBs, including effects on reproduction, pregnancy and on the developmental and neurological systems in infants and young children. 5--11 Several of these studies linked health effects observed in infants, young children and even in adults to their prenatal PCB exposure. 5, 7, 9 Such information may therefore be essential to validate or invalidate hypotheses on causation in epidemiological studies. However, it is not always feasible to link an effect to a measured value of exposure because of the long time lag between the exposure and the onset of that effect. A way to overcome missing measurements of internal levels is to associate an exposure scenario and a model describing the chemical fate in individuals. A physiologically based pharmacokinetic (PBPK) model describes the processes of absorption, distribution, metabolism and excretion, based on the physiology and biochemistry of the organism and the physicochemical properties of the chemical. These models are able to deal with the physiological changes occurring throughout the lifetime of an individual and therefore are adequate tools to simulate the toxicokinetics of persistent pollutants over a lifetime. 12--14 Toxicokinetics are not the sole determinant of internal dosimetry in humans, as the exposure also affects the internal levels of chemicals especially in the case of significant variations during the period of exposure. 15 For example, the year of birth of an individual has been assessed as a major determinant for the lifetime exposure to PCBs. 16, 17 Retrospective time trend studies showed temporal variations of PCBs levels in environment and humans with a peak of exposure in the mid-1970 and an abrupt decrease in the 1980s. 18--24 As food contamination by PCBs has not been monitored frequently in the past and was rarely congener-specific, the major route for human exposure cannot be directly assessed. An alternative to this lack of data is to use exposure models developed for environmental media, for example, atmosphere, 25, 26 and to transpose the environmental model outcomes into time-variant dietary intakes. 16 According to the hypotheses assumed, the shape and the magnitude of the modeled intakes are affected by uncertainty leading to several possible exposure scenarios. 26 Such uncertainty needs to be reduced to use the exposure scenario in epidemiological studies or in the context of risk assessment. Reverse dosimetry is an adequate tool to reconstruct an exposure using biomonitoring data (e.g., blood or urine concentrations of compounds) and a toxicokinetic model. 27--29 In this work, we then propose to perform reverse dosimetry simulations using the exposure scenarios derived from the environmental data, 26 a lifetime PBPK model for PCBs and internal PCBs levels in humans to determine the most likely scenario of exposure (i.e., the shape and magnitude).
Our approach was applied to analyze breast milk levels of Italian primiparous women. The most prevalent PCB congeners detected in human milk were studied: PCB-138 (2,2 0 ,3,4,4 0 ,5 0 -hexachlorobiphenyl), PCB-153 (2,2 0 ,4,4 0 ,5,5 0 -hexachlorobiphenyl) and PCB-180 (2,2 0 ,3,4,4 0 ,5,5 0 -heptachlorobiphenyl). An additional aim of our study was to parameterize the PBPK model for the three congeners with an independent data set to estimate placental transfers, and PCB partitioning into placenta and breast milk.
METHODS

Biomonitoring of Human Milk in Italy
A total of 41 healthy primiparous women, not occupationally exposed to PCBs, were included in our study: 15 women from Giugliano in Campania, 18 from Piacenza and 8 from Milan. These women delivered their babies in 2009 and breast milk samples were collected between 1--3 months after delivery. Women were between 22 and 38 years old. The milk samples and the characteristics of the women have been analyzed previously. 23 Among all the information recorded, only age was correlated with the levels of PCBs in breast milk for most of the PCBs. For women born between 1970 and 1980, the median of the concentration in milk was 17.4 ng/g of fat (2.8--44.5) for PCB-138, 30.9 ng/g of fat (1.4--94.6) for PCB-153 and 24.2 ng/g of fat (3.5--86.3) for PCB-180. For women born from 1981 to 1990, the median of the concentration in milk was 28.1 ng/g of fat (9.3--49.2) for PCB-138, 6.2 ng/g of fat (2.0--26.2) for PCB-153 and 11.2 ng/g of fat (4.0--25.6) for PCB-180.
Dataset to Parameterize the Toxicokinetic Model
An independent study 30 was used to estimate the placental transfers of PCB, and partitioning into placenta and breast milk. This study consisted in getting information about the PCBs toxicokinetics during pregnancy and lactation in the mother and her breast-fed infant by measuring the concentrations of PCBs in samples of four mother/child pairs. Concentrations were measured in the venous blood of the mother, placenta, cord blood and milk. Samples were collected at delivery, and about 5 and 12 months later. For a complete description of the dataset, the reader should refer to Abraham et al. 30 
A Dynamic Exposure Model to Calculate Daily Intakes
The derivation of a daily intake for PCBs requires knowledge of the food contamination with PCBs and the food consumption habits of the population of interest. Valuable information about PCBs contamination was obtained by using the PCBs emissions in the atmosphere to define the timing and the shape of exposure. Atmospheric emissions of the three congeners were predicted with the model developed by Breivik et al. 26 (step 1). This model was built using PCB emission inventories and the global PCB consumption. To take into account for uncertainties in the description of the processes and in parameters values, Breivik et al. 26 derived three time-variant emission profiles (minimum, default and maximum) for each congener to obtain three curves with different shapes. The predicted emissions were then converted into atmospheric concentrations (step 2) by scaling the emissions to air concentrations measured near Piacenza in Italy (Instituto di Ricerche Farmacologiche Mario Negri, personal communication). As the transfer of PCB from air to vegetation and pasture is rapid, 31 the concentrations in air can be transposed into concentrations in food (step 3). 32 The daily intakes were then calculated given the food contamination and the dietary habits of the Italian population (step 4). 33 In the following, these time-variant intakes are qualified as initial intake. We assumed that the intake is an infusion of the same daily dose over 24 h. Redding et al. 13 showed that within a day, the exposure scenario does not impact the results of the PBPK model simulations for PCBs and that a more realistic scenario (i.e., the daily dose divided into three meals) is not necessary.
The same procedure was applied to derive an intake for the German women of the study of Abraham et al. 30 but only the default scenario derived by Breivik et al. 26 was considered.
The PBPK Model for PCBs Model Description. A PBPK model was used to describe the toxicokinetics of PCB-138, PCB-153 and PCB-180 in women over their lifetime with pregnancy and lactation periods. 12 The body is described as a network of tissues and consists of 22 compartments (Figure 1 ). Additional compartments describe the pregnancy and the fetal development (placenta, amniotic fluid and fetus organs). The mother and the fetus are linked by placental transfers. Owing to its detailed description of the human body, the model includes the target organs for PCBs, for example, brain, sexual organs or breast milk.
As food was the only source of exposure considered, the intake was modeled as a direct input into the liver. Distribution of PCBs in the body is managed by blood flow and partitioning into the tissues. In each compartment, the distribution is homogenous. Mass balance equations were established for each compartment as follows:
where Q is the quantity of chemical, F i the blood flow, C art the concentration in arterial blood, C i the concentration in the compartment i, PC i the partition coefficient tissue i:blood, RoE the rate of elimination and RoI the rate of input. Eq. (1) is valid for all compartments but the placenta, as the placental transfers were modeled as diffusion between the sexual organs (mainly uterus in case of the pregnancy) and the placenta. The placental diffusion was scaled to the placenta volume to reach the maximal rate at the end of the placenta growth:
PCBs are poorly metabolized and their elimination occurs mainly via biliary excretion. The elimination of unchanged chemicals was then assumed. We used the equations proposed by Verner et al. 34 to derive the biotransformation and biliary excretion from half-life values. The intrinsic clearance in the liver (CL int ) is defined by:
where Eh is the extraction ratio, F li the liver blood flow and V li the liver volume. The extraction ratio is obtained from:
EhðtÞ ¼ CLðtÞ F li ðtÞ with CLðtÞ ¼ lnð2Þ HLðtÞ ÂVdðtÞ and
where CL is the clearance for the chemical, HL the half-life, Vd is the volume of distribution, PC the tissue:blood partition coefficient, V i the volume of the compartment i and V bl the volume of blood. Information about the age dependence of the enzyme content of the CYP1A2 was also integrated to derive an age-dependent rate of elimination. We used the model developed by Johnson et al. 35 to scale the intrinsic clearance in the liver (CL int ) to the enzyme content in the liver at time t:
where age is in years. Additional excretion through breast milk was modeled as a function of the postpartum age. A logarithmic function was optimized for the milk intake (F milk ) in liter per day with data from Neville et al. 36 :
where AgePP is the postpartum age in days. This function leads to a milk intake around 840 ml/day 6 months after delivery. A linear decrease over 1 week was then assumed to model the stop of the lactation: either the woman chooses partial breast-feeding, then the milk intake reaches 400 ml/day at the end of the week; or the woman stops the breast-feeding, then the milk intake reaches zero.
Model Parameterization for PCBs. Absorption of PCBs via the gastrointestinal tract was set to 100%. Fat:blood partition coefficients were estimated using a quantitative structure--activity relationship (QSAR) specific to PCBs. 37 The other tissue:blood partition coefficients were obtained by multiplying the fat:blood partition coefficients by a factor related to the tissue composition. The changes of the tissue composition from birth to adulthood and the breast milk during lactation were taken into account leading to age-dependent partition coefficients. 38--44 Values for the intrinsic half-lives were taken from the recent study of Ritter et al. 45 No quantitative information was available to assign a value to the placental transfers. The toxicokinetic data of Abraham et al. 30 were then used to estimate this parameter. Parameters values for the PBPK model are given in Table 1 .
Estimation of the Placental Transfers and the Placenta:Blood and Milk:Blood Partition Coefficients
The toxicokinetic data of Abraham et al. 30 were used to estimate the placental transfer (K U2P_init , Eq. (2)). As PCB concentrations were measured in the venous blood of the mother, placenta, cord blood and milk, we also used the data of Abraham et al. 30 to evaluate the placenta:blood and milk:blood partition coefficients obtained with the QSAR. To account for the time evolution of partition coefficients due to changes of the tissues composition during pregnancy and lactation, we defined scaling factors that linked the estimated partition coefficient to that computed with the QSAR. This relationship is given by:
Estimated partition coefficient ¼ scaling factorÂcomputed partition coefficient by QSAR ð7Þ A scaling factor of 1 means that the QSAR prediction perfectly matches the observed data.
To estimate the placental transfers and the placenta:blood and milk:blood partition coefficients, we used the PBPK model described above and the intake specifically derived for women of the Abraham study (see section ''A dynamic exposure model to calculate daily intakes''). 
Reverse Dosimetry
For each PCB congener, three initial intakes (minimum, default and maximum) were available with different shapes and levels of exposure. Several hypotheses were assumed to derive these initial intakes (e.g., assumptions about PCBs production to derive the emission profiles 26 or the linear scaling between concentrations in air and concentrations in food) and the inter-individual variability affecting the dietary intake of each woman (depending on her food consumption habits) was not taken into account. Therefore, these initial intakes may not lead to the observed breast milk concentrations of PCB-138, PCB-153 and PCB-180 in Italian women, but may under or overestimate the milk PCBs levels. Reverse dosimetry simulations were then performed to scale the initial intake to the measured breast milk concentrations. A parameter (named the magnitude) was introduced to relate the initial and estimated intakes:
A magnitude equals to 1 means that the initial intake is likely to explain the observed PCB levels in breast milk. The magnitude was estimated for each woman to allow for inter-individual variations.
Statistical Analyses
The analyses of the Abraham's data and the Italian data set were performed in a Bayesian framework. The data set of the Abraham's mother--child pairs was analyzed before the Italian data set to provide estimates for the PBPK model parameters. Non-informative uniform prior distributions were assigned to parameters to be estimated. Markov Chain Monte Carlo (MCMC) methods were used to numerically obtain a sample of parameter values from their joint posterior distribution. The MCSim software was used. 46 Two independent MCMC chains were run until convergence was reached. Figure 2a presents the simulated concentration in air of PCB-153 between 1945 and 2010 for the three exposure scenarios. These scenarios differ in their levels (i.e., emission in the atmosphere) but also in their shapes (e.g., the rate of decrease after PCB ban, the duration of the period of maximum exposure). The minimum scenario predicts a period of high exposure from 1946 to 1980, and then a large decrease in 1980 (the concentration in air is reduced by a factor of 10 in 4 years). The shape of the maximum scenario is an almost log linear increase from 1946 to the end of the 1970s, and then a very slow decrease until 2010 (a sixfold factor over 30 years). The shape of the default scenario describes a significant increase until the end of the 1970s, then an abrupt decrease and finally a slow log-linear decrease. The year of maximal exposure also differs between the scenarios: 1968, 1973 and 1979 for the minimum, default and maximum scenario, respectively. Figure 2 presents also the initial daily intakes for four women born in different years (1970, 1975, 1980 and 1985) for the default exposure scenario. The shape of the curves is a result of the changing food contamination and dietary habits and is similar for the three congeners. Only the level of the intake is lower for PCB-180 compared with the two other congeners (about a 2.6 factor in 2010). These intakes highlight the importance of the year of birth and reproduce the decrease of PCBs levels in the environment after the 1980s.
RESULTS
Derivation of the Initial Exposure to PCBs
Parameterization of the PBPK Model
The fits of the PBPK model are is in good agreement with the experimental data set of the Abraham study (Figure 3) . The mean deviation between observations and predictions is 28% for the venous blood of the mother, 10% for the placenta, 14% for the cord blood and 19% for breast milk. In breast milk, we observed that the predictions and the observations differ most for the samples having high PCB concentrations. The estimates for the placental transfer and the scaling factors for the partition coefficients placenta:blood and milk:blood are similar for PCB-138 and PCB-153 (Table 1) . For PCB-180, the estimates are lower than those of the two other congeners but not significantly different. Our results indicate that the partition coefficients for milk and placenta predicted by the QSAR are slightly overestimated (scaling factors (Eq. (7)) are significantly lower than 1, Table 1 ). Reducing the partition coefficients by 30--40% for the placenta and 45--60% for breast milk enables good agreement of the model's predictions with the measured concentrations.
Magnitude of the Exposure Profiles
For each Italian woman, the magnitude was estimated for the minimum, default and maximum exposure scenarios and the three congeners (Figure 4 ). The fitted model reproduced the levels measured in milk (R 2 between 0.97 and 0.99). For women born before 1980 childhood and adolescence fell during the period of the highest exposure to PCBs, and adulthood in relatively low exposure period, whereas woman born after 1980 lived during the lowest exposure period (Figure 2) . The women were then separated into two groups (born before or after 1980) to check the ability of the exposure model to describe these two periods with similar magnitudes. Such a result indicates that the shape of the exposure model is likely to describe the changes of PCBs contamination in food for women born after 1970. When magnitudes differ between the two groups, this means that the same exposure profile (shape and magnitude) is not suitable for the two groups of women. This situation occurs for all the minimum scenarios, which assume a very high decrease in the PCBs levels before and after 1980 (Figure 2a ). These scenarios are thus unlikely able to describe the actual PCBs contamination. For each congener, we selected the most probable exposure scenario, that is, the scenario for which the medians of the magnitudes were similar or the closest between the two groups of women. The default scenario was selected for PCB-153 and PCB-180, and the maximum scenario for PCB-138. For PCB-180, the two groups fit perfectly, whereas the similarity is moderate for PCB-138 and PCB-153. A magnitude close to 1 means that the level of the initial intake is likely to explain the observed PCB levels in breast milk. For PCB-153, the median of the magnitudes is 0.20 implying that only 20% of the initial intake is needed to reach the observed levels. For PCB-138, only 66% of the initial intake is enough. For PCB-180, the median of the individual magnitudes is 1, indicating that the initial intake is able to reproduce the observed milk concentrations.
Inter-Individual Variability Significant inter-individual variability was observed between the magnitudes. Factors of about 20 and 23 are observed between the minimum and the maximum predicted magnitude for PCB-138 and PCB-180, respectively. This factor reaches 83 for PCB-153 because of a woman exhibiting very low levels in milk (1.4 ng/g fat in milk for a woman born in 1972). If this woman is excluded, the inter-individual variability for PCB-153 is similar to those of the two other congeners (about 27). The predicted inter-individual variability reproduces the variability observed in the measured milk levels. For example, a level of 86.3 ng/g fat in milk was measured for PCB-180 in a woman born in 1974 and that level was 3.5 ng/g fat in milk in a woman born in 1975 (so a factor 23).
DISCUSSION
In this study, we aimed at reconstructing the dietary intake of Italian women to three PCB congeners (PCB-138, PCB-153 and PCB-180) using measurements in breast milk and a modeling approach combining dynamic exposure scenarios and a PBPK model. These exposure scenarios associated with the PBPK model enable to simulate internal levels of the PCB congeners in different populations of Italian women (e.g., children, teenagers and adult womeny) and can therefore be used in epidemiological studies.
For each congener of interest, we were able to determine the most probable scenario of exposure. For PCB-180, the perfect concordance between the model predictions and the biomonitoring data supports the relevance of the models. For PCB-138 and PCB-153, the results are moderate as we observed temporal trends in the estimated magnitudes. These time variations are minimized for the default and the maximum exposure scenario for PCB-153 and PCB-138, respectively. According to the estimated magnitudes for the default scenario of PCB-153, we may conclude that the gap between the exposure levels before and after 1980 has to be increased compared with the one defined in the default scenario. For PCB-138, the similarity of the milk levels in women born before or after 1980 is not reproducible by our models: either the shape of the exposure model is not suitable (according to the measured levels in milk, a constant exposure since the 1970s might be tested), or past exposure do not significantly impact the current milk levels, meaning that the half-life of PCB-138 should be lowered. Such indications should help in deriving new exposure scenarios, for example, in favoring hypotheses supporting our conclusions, or in refining information on toxicokinetic processes.
The daily intakes estimated by the most probable exposure scenarios are similar to those derived from exposure assessments
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Maximum scenario for PCB-180 Figure 4 . Magnitudes of the intake profiles for the maximum, default and minimum scenarios. Women were separated into two groups: women born before 1981, and women born after 1981. A magnitude close to 1 means that the predicted exposure scenario is likely to explain the observed PCB levels in human milk.
based solely on food contamination and consumption (Table 2) . Our estimates for PCB-138 and PCB-180 in 1998 perfectly match with those derived by Zuccato et al., 47 whereas the estimates for PCB-153 differ by a factor of 3 with a similar coefficient of variation (100%). We also considered the study of Arnich et al. 48 that assessed the dietary intakes of six non-dioxin-like PCBs indicators in 2002--2006 in France (considering that food contamination and consumption are similar in France and Italy). Assuming that the three congeners represent about 70% of the dietary intake of the PCBs indicators, 32 the intakes are similar for women but differ slightly for children (our predicted intake is 60% superior of their intake). These results support the relevance of our approach to reconstruct accurately the exposure of a population and to fill in the data gaps on dietary intake for the last 15 years. The lack of intake assessments and congener-specific food contamination surveys in the 1970s and 1980s precludes any comparison for that period.
In our study, we considered one biomonitoring study in Italian primiparous women born after 1970. Even if a large interindividual variability is observed in this group of women, they are not a representative sampling of Italian women. Then additional data might be integrated in our analysis to derive a robust intake for the Italian population. Our modeling approach is able to deal with biomonitoring data obtained in heterogeneous populations. Indeed, the time-variant exposure model allows considering data collected at different years and the PBPK model is able to describe the PCB toxicokinetics in individuals with different history, such as the number of pregnancy and lactation periods, the womans age at the beginning of the pregnancy. We can expect that the higher number of data in the analysis, the more accurate the results will be. However, the inclusion of new data sets may increase uncertainty (e.g., inter-study variability or different analytical protocols) that already affects the process of exposure reconstruction.
In exposure reconstruction, uncertainty may concern either the toxicokinetics or the exposure. 49 We limited the impact by using a PBPK model describing the physiological variations that affect the PCBs toxicokinetics over lifetime 12 and an exposure model predicting different scenarios. 26 The PBPK model was improved to account for the PCBs placental transfers using a diffusion constant relative to the placenta's weight instead of assuming equal partitioning (adjusted to the lipid content) between maternal and fetal bloods. This modeling enables an accurate description of the kinetics of PCBs, as blood or serum levels are usually higher in the mother than in the fetus. 30, 50 The PBPK model was parameterized with values 45 and data sets 30 that are independent of our biomonitoring data. No inter-individual variability was modeled for the toxicokinetic processes. It is well known that excretion is subject to appreciable variations between individuals, but this toxicokinetic variability is usually not taken into account in exposure reconstruction. 49 In case of scarce data, it might be impossible to separate and quantify the variability observed in the human levels into variability affecting the toxicokinetics and the exposure. In our analysis, we then assumed that only the dietary intake was subject to inter-individual variability.
The characterization of the exposure was based on modeled PCBs emissions. The resort to predicted data has been encouraged to overcome the lack of information for a specific process in a modeling approach 51 and was used here to replace the absence of measurement of food contamination. The predicted emissions were used to characterize the shape and the timing of the exposure profile, such as the year of the peak of emissions and the decreasing intensity during the post-ban period. Simple relationships were then used to transpose these emissions profiles into dietary intake profiles using data on atmospheric concentrations, food contamination and dietary habits. Even if some relationships are based on experimental observations, 31 some processes are skipped such as biomagnification and bioaccumulation through the food chain. Our modeling approach might then be improved by modeling other environmental media (such as soil, plants and animals) and their interactions to lead to a reduced uncertainty in the derived intake. 52 
CONCLUSION
In this study, we aimed to reconstruct the exposure of Italian women to three PCBs using measurements in breast milk, timevariant exposure scenarios and PBPK modeling. For each congener, we were able to determine the most probable scenario of exposure and to estimate the time evolution of the daily intakes over the lifetime. The intake estimates are in good agreement with previous exposure assessments demonstrating the relevance of our approach to reconstruct accurately the exposure and to fill in data gaps on exposure. The link between the exposure scenario and biomonitoring data was provided by the PBPK model to support the adequacy of the models according to the data (e.g., for PCB-180) or to identify possible improvements for the exposure and PBPK models (e.g., for PCB-138 and PCB-153). 
